Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis

MLA

Georgia Trakada, et al. “Pulmonary Function Tests Reveal Unrecognised Lung Dysfunction and Have Independent Prognostic Significance in Patients with Systemic AL Amyloidosis.” Amyloid, Oct. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.1080/13506129.2022.2136519.

APA

Georgia Trakada, Despina Fotiou, Anastasios Kallianos, Foteini Theodorakakou, Magdalini Migkou, Maria Gavriatopoulou, Nikolaos Kanellias, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Evangelos Eleutherakis-Papaiakovou, Ioanna Dialoupi, Evangelos Terpos, Meletios A. Dimopoulos, & Efstathios Kastritis. (2022). Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis. Amyloid, 1–8. https://doi.org/10.1080/13506129.2022.2136519

Chicago

Georgia Trakada, Despina Fotiou, Anastasios Kallianos, Foteini Theodorakakou, Magdalini Migkou, Maria Gavriatopoulou, Nikolaos Kanellias, et al. 2022. “Pulmonary Function Tests Reveal Unrecognised Lung Dysfunction and Have Independent Prognostic Significance in Patients with Systemic AL Amyloidosis.” Amyloid, October, 1–8. doi:10.1080/13506129.2022.2136519.